Topics

Purpose The National Institutes of Health (NIH) participating Institutes and Centers (ICs), in coordination with the U.S. Food and Drug Administration (FDA), invite cooperative agreement (UT2) applications that will support small business research studies aimed at furthering the field of regenerative medicine (RM) using adult stem cells. These applications are expected to focus on innovative proj ...

Purpose The National Institutes of Health (NIH) participating Institutes and Centers (ICs), in coordination with the U.S. Food and Drug Administration (FDA), invite cooperative agreement (U44) applications to support small business research studies aimed at furthering the field of regenerative medicine (RM) using adult stem cells. These applications are expected to focus on innovative projects th ...

NCATS Topics This solicitation invites proposals in the following areas: 016 Synthetic Technologies for Advancement of Research and Therapeutics (START) Fast-Track proposals will not be accepted. Number of anticipated awards: 1-2 Budget (total costs, per award): Phase I: $225,000 for 9 months; Phase II: $1,500,000 for 2 years PROPOSALS THAT EXCEED THE BUDGET OR PROJECT DURATION L ...

017 Universal Medium/Blood Mimetic for Use in Integrated Organs-on-Chips Fast-Track proposals will not be accepted. Number of anticipated awards: 1-2 Budget (total costs, per award): Phase I: $225,000 for 9 months; Phase II: $1,500,000 for 2 years PROPOSALS THAT EXCEED THE BUDGET OR PROJECT DURATION LISTED ABOVE MAY NOT BE FUNDED. Phase II information is provided only for informationa ...

018 Non-PDMS Biocompatible Alternatives for Organs-on-Chips Fast-Track proposals will not be accepted. Number of anticipated awards: 1-2 Budget (total costs, per award): Phase I: $225,000 for 9 months; Phase II: $1,500,000 for 2 years PROPOSALS THAT EXCEED THE BUDGET OR PROJECT DURATION LISTED ABOVE MAY NOT BE FUNDED. Phase II information is provided only for informational purpos ...

　 382 Integrated Subcellular Microscopy and ‘Omics in Cancer Cell Biology Fast track proposals will be accepted. Number of anticipated awards: 2-3 Budget (total costs, per award): Phase I: up to $300,000 for up to 9 months; Phase II: up to $2,000,000 for up to 2 years PROPOSALS THAT EXCEED THE BUDGET OR PROJECT DURATION LISTED ABOVE MAY NOT BE FUNDED. Summary Advances in microscop ...

  383 Smart, Multi-Core Biopsy Needle Fast track proposals will be accepted. Number of anticipated awards: 2-3 Budget (total costs, per award): Phase I: up to $300,000 for up to 9 months; Phase II: up to $2,000,000 for up to 2 years PROPOSALS THAT EXCEED THE BUDGET OR PROJECT DURATION LISTED ABOVE MAY NOT BE FUNDED. Summary Tumor recurrence or resistance to treatment of ...

  384 Digital Healthcare Platform to Reduce Financial Hardship for Cancer Patients Fast-Track proposals will be accepted. Number of Anticipated Awards: 2-3 Budget (total costs, per award): Phase I: up to $300,000 for up to 9 months; Phase II: up to $2,000,000 for up to 2 years PROPOSALS THAT EXCEED THE BUDGET OR PROJECT DURATION LISTED ABOVE MAY NOT BE FUNDED. Summary The cost of can ...

Fast-Track proposals will be accepted. Number of Anticipated Awards: 2-3 Budget (total costs, per award): Phase I: up to $225,000 for up to 9 months; Phase II: up to $1,500,000 for up to 2 years PROPOSALS THAT EXCEED THE BUDGET OR PROJECT DURATION LISTED ABOVE MAY NOT BE FUNDED. Summary One of the consequences of living longer is the symptom burden of cancer survivorship, which is having a s ...

  386 Novel Approaches for Local Delivery of Chemopreventive Agents Fast-Track proposals will be accepted. Number of Anticipated Awards: 2-4 Budget (total costs, per award): Phase I: up to $300,000 for up to 9 months; Phase II: up to $2,000,000 for up to 2 years PROPOSALS THAT EXCEED THE BUDGET OR PROJECT DURATION LISTED ABOVE MAY NOT BE FUNDED. Summary The clinical value of an a ...